Tag:
NovoSeven
Latest Headlines
Latest Headlines
Blood drug's off-label use may have 'scary' consequences
Here's a story about the pitfalls off-label drug use. The clot-promoting drug NovoSeven, approved for patients who lack a particular clotting gene or those who can't tolerate an alternative
Novo Nordisk discontinues Phase III on disappointing results
Concluding that a late-stage trial of its experimental therapy to prevent bleeding in trauma patients was headed to a likely failure, Novo Nordisk discontinued the study of
